Kashiwazaki H - Search Results

1

Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues.

Hassan NM, Hamada J, Murai T, Seino A, Takahashi Y, Tada M, Zhang X, Kashiwazaki H, Yamazaki Y, Inoue N, Moriuchi T. Hassan NM, et al. Among authors: kashiwazaki h. Oncol Res. 2006;16(5):217-24. doi: 10.3727/000000006783981080. Oncol Res. 2006. PMID: 17294802

2

Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma.

Kashiwazaki H, Hassan NM, Hamada J, Moriuchi T, Yamazaki Y, Tei K, Totsuka Y, Inoue N. Kashiwazaki H, et al. Odontology. 2008 Jul;96(1):38-43. doi: 10.1007/s10266-008-0084-1. Epub 2008 Jul 27. Odontology. 2008. PMID: 18661203

3

Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues.

Hassan NM, Hamada J, Kameyama T, Tada M, Nakagawa K, Yoshida S, Kashiwazaki H, Yamazaki Y, Suzuki Y, Sasaki A, Nagatsuka H, Inoue N, Moriuchi T. Hassan NM, et al. Among authors: kashiwazaki h. Asian Pac J Cancer Prev. 2011;12(4):947-51. Asian Pac J Cancer Prev. 2011. PMID: 21790231 Free article.

4

Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.

Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Fukuda H. Yamazaki Y, et al. Among authors: kashiwazaki h. Oral Oncol. 2003 Feb;39(2):163-9. doi: 10.1016/s1368-8375(02)00064-7. Oral Oncol. 2003. PMID: 12509970

5

Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.

Yamazaki Y, Chiba I, Hirai A, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Iizuka T, Kohgo T, Fukuda H. Yamazaki Y, et al. Among authors: kashiwazaki h. Am J Clin Oncol. 2003 Oct;26(5):e124-9. doi: 10.1097/01.coc.0000091352.60347.f8. Am J Clin Oncol. 2003. PMID: 14528086

6

Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer.

Hassan NM, Tada M, Hamada J, Kashiwazaki H, Kameyama T, Akhter R, Yamazaki Y, Yano M, Inoue N, Moriuchi T. Hassan NM, et al. Among authors: kashiwazaki h. Cancer Lett. 2008 Oct 18;270(1):108-19. doi: 10.1016/j.canlet.2008.04.052. Epub 2008 Jun 13. Cancer Lett. 2008. PMID: 18555592

7

A multiple primary carcinoma consisting of leukoplakia and SCC: a case report with p53 mutation analysis.

Hassan NM, Tada M, Shindoh M, Hamada J, Kashiwazaki H, Shimo T, Ashikaga Y, Yamazaki Y, Sasaki A, Moriuchi T, Inoue N. Hassan NM, et al. Among authors: kashiwazaki h. Anticancer Res. 2010 Nov;30(11):4773-8. Anticancer Res. 2010. PMID: 21115940

8

Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells.

Nakazawa S, Sakata KI, Liang S, Yoshikawa K, Iizasa H, Tada M, Hamada JI, Kashiwazaki H, Kitagawa Y, Yamazaki Y. Nakazawa S, et al. Among authors: kashiwazaki h. Biomed Res. 2019;40(1):37-49. doi: 10.2220/biomedres.40.37. Biomed Res. 2019. PMID: 30787262 Free article.

9

Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.

Marutani M, Tonoki H, Tada M, Takahashi M, Kashiwazaki H, Hida Y, Hamada J, Asaka M, Moriuchi T. Marutani M, et al. Among authors: kashiwazaki h. Cancer Res. 1999 Oct 1;59(19):4765-9. Cancer Res. 1999. PMID: 10519380

10

High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.

Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R, Moriuchi T. Kashiwazaki H, et al. Oncogene. 1997 Nov 27;15(22):2667-74. doi: 10.1038/sj.onc.1201438. Oncogene. 1997. PMID: 9400993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters